Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Str8Shuteron Nov 20, 2020 12:53pm
108 Views
Post# 31941523

RE:RE:RE:RE:RE:IR

RE:RE:RE:RE:RE:IRThat is indeed a fair question.  I think that the key here is that if someone wanted to buy a few thousand or tens of thousands of shares, they could grab some right now at a good price.  A few at a time, if they are patient.  The risk is that the SP elevates in the meantime, raising their ACB, and possibly even resulting in the proverbial "missing the boat" if a positive NR occurs in the meantime before they are able to buy all the shares that they really wanted.

However, if a serious Accredited investor wanted to grab a serious number of shares in the short term, at a guaranteed set price, the best way to do so would be via the Offering because there are millions of shares available, as outlined in the Prospectus.

At least, that's my two cents.  GLTA!

Bully88 wrote: Genuine question/ concern here,

Do major institutions invest in a PP at a certain price if the stock is strading .10 - .15 cents below the offering?

if an institution has agreed to buy at a certain price but the shares go down the way they have today, do they have the option to back out and just buy at the lower price?

would this be a risk of not having anybody participate in the offering?

thank you for your informed, eductated responces.

Cheers,

Bully




Bullboard Posts